| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |